ea0015p91 | Clinical practice/governance and case reports | SFEBES2008
Chung Teng-Teng LL
, Kelly Phillip
, Metcalfe Karl
, Akker Scott
, Drake William
, Monson John
The potential for primary tumour relapse is an important consideration during GH replacement therapy (GHR). We report 3 cases of relapse of intra cranial germ cell tumour (GCT) during GHR.Patient 1: An 11 year-old female presenting with visual loss and short stature due to a suprasellar malignant teratoma. She was successfully treated with bleomycin, etoposide and cisplatinum (BEP) and intrathecal chemotherapy. She suffered a first relapse two years late...